Psyence Graham Number from 2010 to 2026

PBM Stock  USD 0.72  0.05  6.49%   
Psyence Biomedical Graham Number yearly trend continues to be very stable with very little volatility. Graham Number is likely to grow to 20.58 this year. During the period from 2010 to 2026, Psyence Biomedical Graham Number quarterly data regression pattern had sample variance of  40.55 and median of  6.41. View All Fundamentals
 
Graham Number  
First Reported
2010-12-31
Previous Quarter
19.6
Current Value
20.58
Quarterly Volatility
6.36757323
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Psyence Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Psyence Biomedical's main balance sheet or income statement drivers, such as Net Interest Income of 104.5 K, Interest Income of 115.7 K or Selling General Administrative of 2.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.39. Psyence financial statements analysis is a perfect complement when working with Psyence Biomedical Valuation or Volatility modules.
  
Build AI portfolio with Psyence Stock
Check out the analysis of Psyence Biomedical Correlation against competitors.
Evaluating Psyence Biomedical's Graham Number across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Psyence Biomedical Ltd's fundamental strength.

Latest Psyence Biomedical's Graham Number Growth Pattern

Below is the plot of the Graham Number of Psyence Biomedical Ltd over the last few years. It is Psyence Biomedical's Graham Number historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Psyence Biomedical's overall financial position and show how it may be relating to other accounts over time.
Graham Number10 Years Trend
Slightly volatile
   Graham Number   
       Timeline  

Psyence Graham Number Regression Statistics

Arithmetic Mean9.83
Geometric Mean8.46
Coefficient Of Variation64.80
Mean Deviation5.23
Median6.41
Standard Deviation6.37
Sample Variance40.55
Range15.3716
R-Value0.73
Mean Square Error20.28
R-Squared0.53
Significance0.0009
Slope0.92
Total Sum of Squares648.74

Psyence Graham Number History

2026 20.58
2025 19.6
2023 21.78
2022 6.43

About Psyence Biomedical Financial Statements

Psyence Biomedical investors utilize fundamental indicators, such as Graham Number, to predict how Psyence Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Graham Number 19.60  20.58 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Psyence Biomedical is a strong investment it is important to analyze Psyence Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psyence Biomedical's future performance. For an informed investment choice regarding Psyence Stock, refer to the following important reports:
Check out the analysis of Psyence Biomedical Correlation against competitors.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Will Biotechnology sector continue expanding? Could Psyence diversify its offerings? Factors like these will boost the valuation of Psyence Biomedical. Anticipated expansion of Psyence directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Psyence Biomedical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(62.40)
Return On Assets
(0.34)
Return On Equity
(0.74)
Psyence Biomedical's market price often diverges from its book value, the accounting figure shown on Psyence's balance sheet. Smart investors calculate Psyence Biomedical's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Psyence Biomedical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Psyence Biomedical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Psyence Biomedical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.